Publications for Amanda Nordigården
Co-author map based on ISI articles 2007-

Journal Articles

Amanda Nordigården, Jenny Zetterblad, Cecilia Trinks, Henrik Green, Pernilla Eliasson, Pia Druid, Kourosh Lotfi, Lars Ronnstrand, Thomas Walz and Jan-Ingvar Jönsson
  Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice
  British Journal of Haematology, 2011, 155(2), 198-208.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Amanda Nordigården, Maria Kraft, Pernilla Eliasson, Verena Labi, Eric W.-F Lam, Andreas Villunger and Jan-Ingvar Jönsson
  BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3.
  Blood, 2009, 113(10), 2302-2311.
 Web of Science® Times Cited: 15

Rajesh Mishra, Karin Sörgjerd, Sofie Nyström, Amanda Nordigården, Yu-Jui Chiu and Per Hammarström
  Lysozyme Amyloidogenesis Is Accelerated by Specific Nicking and Fragmentation but Decelerated by Intact Protein Binding and Conversion
  Journal of Molecular Biology, 2007, 366(3), 1029-1044.
 Web of Science® Times Cited: 67

Anneli Karlsson, Amanda Nordigården, Jan-Ingvar Jönsson and Peter Söderkvist
  Bcl11b mutations identified in murine lymphomas increase the proliferation rate in hematopoietic progenitor cells
  BMC Cancer, 2007, 7(195), 195.
   Fulltext  PDF  
 Web of Science® Times Cited: 6

Conference Articles

Amanda Nordigården, Camilla Halvarsson, Yan-juan Tang, Pia Druid and Jan-Ingvar Jönsson
  A COMPARATIVE STUDY OF VARIOUS FLT3-ITD MUTATIONS ISOLATED FROM ACUTE MYELOID LEUKEMIA PATIENTS in EXPERIMENTAL HEMATOLOGY, vol 40, issue 8, pp S130-S131
  EXPERIMENTAL HEMATOLOGY, 2012.


Ph.D. Theses

Amanda Nordigården
  The FLT3 Tyrosine Kinase in Leukemia: Deciphering the Downstream Signaling Events and Drug-Escape Mechanisms
  2013.


  Fulltext PDF